SEARCH

SEARCH BY CITATION

References

  • 1
    Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE 2009; 4: e4439.
  • 2
    Dean B, Barber N. A validated, reliable method of scoring the severity of medication errors. Am J Health Syst Pharm 1999; 56: 5762.
  • 3
    Dornan T, Ashcroft D, Heathfield H, Lewis P, Taylor D, Tully MP, Wass V. An in depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education. EQUIP study. 2009.
  • 4
    Avery T, Barber N, Ghaleb MA, Dean Franklin B, Armstrong S, Crowe S, Dhillon S, Freyer A, Howard R, Pezzolesi C, Serumaga B, Swanwick G, Talabi O. Investigating the prevalence and causes of prescribing errors in general practice: the PRACtICe Study. A report for the GMC: General Medical Council, 2012.
  • 5
    Griffin FA, Resar RK. IHI Global Trigger Tool for Measuring Adverse Events (Second Edition). IHI Innovation Series White Paper. Cambridge, MA: Institute for Healthcare Improvement, 2009.
  • 6
    The Information Centre (Health Care). The Prescribing toolkit. Available at http://www.ic.nhs.uk/prescribing/measures (last accessed 22 August 2012).
  • 7
    Avery AJ, Dex GM, Mulvaney C, Serumaga B, Spencer R, Lester HE, Campbell SM. Development of prescribing-safety indicators for GPs using the RAND Appropriateness Method. Br J Gen Pract 2011; 61: e526536.
  • 8
    Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 7283.
  • 9
    Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 2007; 63: 725731.
  • 10
    NSW Therapeutic Advisory Group. Indicators for quality use of medicines in Australian hospitals. Available at http://www.ciap.health.nsw.gov.au/nswtag/reviews/indicators.html (last accessed 3 January 2013).
  • 11
    Schedlbauer A, Prasad V, Mulvaney C, Phansalkar S, Stanton W, Bates DW, Avery AJ. What evidence supports the use of computerized alerts and prompts to improve clinicians' prescribing behavior? J Am Med Inform Assoc 2009; 16: 531538.
  • 12
    Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003; 163: 14091416.
  • 13
    Pearson SA, Moxey A, Robertson J, Hains I, Williamson M, Reeve J, Newby D. Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990–2007). BMC Health Serv Res 2009; 9: 154.
  • 14
    Avery AJ, Savelyich BSP, Sheikh A, Cantrill J, Morris CJ, Fernando B, Bainbridge M, Horsfield P, Teasdale S. Identifying and establishing consensus on the most important safety features of GP computer systems: e-Delphi study. Inform Prim Care 2005; 13: 312.
  • 15
    NIHR Programme Grant for Applied Research. E-prescribing: everything you want to know but were afraid to ask! A symposium for the health service. Available at http://www.cphs.mvm.ed.ac.uk/projects/eprescribing/index.html (last accessed 11 November 2012).
  • 16
    Avery AJ, Dex GM, Mulvaney C, Serumaga B, Spencer R, Lester HE, Campbell SM. Development of prescribing-safety indicators for GPs using the RAND Appropriateness Method. Br J Gen Pract 2011; 61: e526536.
  • 17
    Phansalkar S, Desai AA, Bell D, Yoshida E, Doole J, Czochanski M, Middleton B, Bates DW. High-priority drug–drug interactions for use in electronic health records. J Am Med Inform Assoc 2012; 19: 735743.
  • 18
    British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary. Available at http://www.bnf.org (last accessed 1 March 2012).
  • 19
    National Patient Safety Agency. Available at http://www.npsa.nhs.uk (last accessed 1 March 2012).
  • 20
    Medicines and Healthcare products Regulatory Agency. Available at http://www.mhra.gov.uk (last accessed 1 March 2012).
  • 21
    National Patient Safety Agency. A risk matrix for risk managers, 2008.
  • 22
    Fitch K, Bernstein SJ, Aguilar MS, Burnand B, LaCalle JR, Lazaro P, van het Loo M, McDonnell J, Vader J, Kahan JP. The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, CA: RAND, 2001.
  • 23
    Cousins DH, Gerrett D, Warner B. A review of medication incidents reported to the National Reporting and Learning System in England and Wales over six years (2005–2010). Br J Clin Pharmacol 2011; 74: 597604.
  • 24
    The NHS Health and Social Care Information Centre. Prescriptions dispensed in the community: England, statistics for 2001 to 2011, 2012.
  • 25
    Classen D, Phansalkar S, Bates D. Critical drug-drug interactions for use in electronic health records systems with computerized physician order entry: review of leading approaches. J Patient Saf 2011; 7: 6165.
  • 26
    National Patient Safety Agency. Safety in doses: improving the use of medicines in the NHS. 2008.
  • 27
    van der Sijs H, Aarts J, van Gelder T, Berg M, Vulto A. Turning off frequently overridden drug alerts: limited opportunities for doing it safely. J Am Med Inform Assoc 2008; 15: 439448.
  • 28
    Riedmann D, Jung M, Hackl WO, Stuhlinger W, van der Sijs H, Ammenwerth E. Development of a context model to prioritize drug safety alerts in CPOE systems. BMC Med Inform Decis Mak 2011; 11: 35.
  • 29
    Shojania KG, Jennings A, Mayhew A, Ramsay CR, Eccles MP, Grimshaw J. The effects of on-screen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev 2009; (3): CD001096.